Limitations
ethamyslate
The main limitation of this RCT is the scant number of published RCTs in this field. The amount of evidence that is now available on this topic is still insufficient to draw solid conclusions about the efficacy of the discussed therapies. Future research should compare prophylactic oxytocin against TA with ethamyslate among myomectomy patients pre- and post-operatively in additional multicenter, large-sized, and well-controlled RCTs.